Chacko David M. — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Chacko David M. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Profile
David M. Chacko is the Chief Financial Officer (CFO) and Chief Business Officer (CBO) of Erasca, Inc., a clinical-stage oncology company focused on RAS/MAPK pathway–driven cancers. In Erasca's SEC filing context as of January 30, 2026 (CIK 0001871801), he is listed in leadership roles with no reported equity purchases or sales during that filing period.
Role
Insider
Notability
60/100
Board memberships
Erasca, Inc.
Awards & honors
Listed as CFO and CBO of Erasca, guiding financial strategy and corporate development.
Oversees budgeting, financial reporting, and strategic partnerships for a clinical-stage oncology company.
David M. Chacko is the Chief Financial Officer (CFO) and Chief Business Officer (CBO) of Erasca, Inc., a clinical-stage oncology company focused on RAS/MAPK pathway–driven cancers. In Erasca's SEC filing context as of January 30, 2026 (CIK 0001871801), he is listed in leadership roles with no reported equity purchases or sales during that filing period.…
Where can I see all of Chacko David M.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
